Skip to main content
All lobbying filings

Buchanan Ingersoll & Rooney PC

Buchanan Ingersoll & Rooney PC filed a Q1 report for Bright Path Labs on April 20, 2026, reporting $30,000 in lobbying income.

Lobbying for Bright Path Labs · Pharmaceutical company

As filed: BUCHANAN INGERSOLL & ROONEY PC for BRIGHT PATH LABS.

All filings by Buchanan Ingersoll & Rooney PC · Everything Bright Path Labs has reported

 Filing · LD-2 quarterly report Q1 report
Reporting period
1st Quarter 2026
Jan 1 - Mar 31 · Posted Apr 20, 2026
Income
$30,000
What the client paid this registrant for the period.
Client based in
North Carolina

Official filing document

 Government bodies contacted 7

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 6

Develop and execute a government relations strategy on issues relevant to Bright Path Labs.

Develop and execute a government relations strategy on issues relevant to Bright Path Labs.

Develop and execute a government relations strategy on issues relevant to Bright Path Labs.

Develop and execute a government relations strategy on issues relevant to Bright Path Labs.

Develop and execute a government relations strategy on issues relevant to Bright Path Labs.

Develop and execute a government relations strategy on issues relevant to Bright Path Labs.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem